we'd like to see that, but realistically one has to look at the share count- now over 2.2 billion, with more on the way. I know this is a start-up bio-tech., and the shares are going for a great cause, but it still makes it difficult to push the pps up.
the pps hit the yearly high when they submitted the ind app., so I would think we'll see a new high on approval news. how high ?
it really depends, will we get additional news ? orphan status?
so remember- there are a lot of variables to determine the pps. but I think its safe to say .02-.03 is reasonable.
